An apple a day might help keep the doctor away, but a growing body of evidence supports the fact that a drink or two has healthful benefits. A new study by the Mount Sinai School of Medicine has found moderate red wine consumption in the form of cabernet sauvignon may help reduce the incidence of Alzheimer's Disease. The study is set to be published in the November issue of the FASEB Journal and will be presented at the Society for Neuroscience meeting in Atlanta in October.
In the Mount Sinai research, cabernet sauvignon was diluted with water and given to mice. Researchers Dr. Giulio Maria Pasinetti and Dr. Jun Wang wrote, "This study supports epidemiological evidence indicating that moderate wine consumption, within the range recommended by the FDA dietary guidelines of one drink per day for women and two for men, may help reduce the relative risk for Alzheimer's Disease clinical dementia."
People with Alzheimer's Disease have elevated levels of amyloid peptides that cause plaque to buildup in blood vessels in the brain. An estimated 4.5 million Americans suffer from the disease. The research suggests that moderate red wine consumption helps the body safely process amyloid peptides.